I think MRK offers a terrific low risk long here, a great biotech company to own in this particular juncture. IBB is acting very strong, there is a monthly uptrend active currently in the sector, so, finding the strongest contenders will yield great returns going forward.
Best of luck,
Ivan Labrie.
Zlecenie aktywne
⋅
I had bought last Friday, again. I was long and banked profits before the recent correction.
Komentarz
⋅
Good to buy back soon -or add-
Zlecenie zamknięto ręcznie
⋅
I'm closing MRK here, the FDA news really killed it's move. s3.amazonaws.com/tradingview/snapshots/p/Pr8Wmc4Y.png Technically we would need to wait a bit longer but there is no need to expose ourselves to extra risk in the sector. We can buy back when the chart and news give us a good reason to.